Amiodarone pulmonary toxicity - three unusual manifestations
- 1 February 1992
- journal article
- case report
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 22 (1) , 14-18
- https://doi.org/10.1111/j.1445-5994.1992.tb01702.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Role of phospholipase A inhibition in amiodarone pulmonary toxicity in ratsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapyInternational Journal of Cardiology, 1985
- Amiodarone pulmonary toxicityAmerican Heart Journal, 1983
- Low-Dose Steroid Therapy for Prophylaxis of Amiodarone-Induced Pulmonary InfiltratesNew England Journal of Medicine, 1983
- Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug.Circulation, 1982
- AmiodaroneNew England Journal of Medicine, 1981
- Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone.Circulation, 1981
- Control of refractory life-threatening ventricular tachyarrhythmias by amiodaroneAmerican Heart Journal, 1981
- Possible association of pneumonitis with amiodarone therapyAmerican Heart Journal, 1980
- Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochlorideThe American Journal of Cardiology, 1974